Allergenicity, immunogenicity and dose-relationship of three intact allergen vaccines and four allergoid vaccines for subcutaneous grass pollen immunotherapy

Clinical and Experimental Immunology

Volumn 153, Issue 3, 2008, Pages 316-323

  Henmar, H ^a,b   Lund, G ^a   Lund, L ^a   Petersen, A ^a   Wurtzen P A ^a  

^a ALK ABELLÓ   (Denmark)

^b NONE   (Denmark)

Author keywords

Allergy; Basophil; T cell

Indexed keywords

ALK7; ALLERGOVIT; ALUTARD SQ; DEPIGOID; IMMUNOGLOBULIN G ANTIBODY; PANGRAMIN PLUS; POLLEN ANTIGEN; POLLINEX QUATTRO; PURETHAL; UNCLASSIFIED DRUG; VACCINE;

ALLERGENICITY; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BASOPHIL; CHEMICAL MODIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; GRASS POLLEN; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHLEUM PRATENSE; POLLEN ALLERGY; PRIORITY JOURNAL; T LYMPHOCYTE;

ALLERGENS; ANIMALS; BASOPHILS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; POACEAE; POLLEN; T-LYMPHOCYTES; VACCINES;

EID: 49649086915     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03710.x     Document Type: Article

References (28)

1. Bousquet J, Lockey RF, Malling HJ. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998 53 : 1 42.
2. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007 CD001936.
3. Marsh DG, Lichtenstein LM, Campbell DH. Studies on 'allergoids' prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology 1970 18 : 705 22.
4. Casanovas M, Fernandez-Caldas E, Alamar R, Basomba A. Comparative study of tolerance between unmodified and high doses of chemically modified allergen vaccines of Dermatophagoides pteronyssinus. Int Arch Allergy Immunol 2005 137 : 211 18.
5. Cirkovic TD, Bukilica MN, Gavrovic MD, Vujcic ZM, Petrovic S, Jankov RM. Physicochemical and immunologic characterization of low-molecular-weight allergoids of Dactylis glomerata pollen proteins. Allergy 1999 54 : 128 34.
6. Kahlert H, Cromwell O, Fiebig H. Measurement of basophil-activating capacity of grass pollen allergens, allergoids and hypoallergenic recombinant derivatives by flow cytometry using anti-CD203c. Clin Exp Allergy 2003 33 : 1266 72.
7. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990 85 : 490 7.
8. Lund L, Henmar H, Würtzen PA, Lund G, Hjortskov N, Larsen JN. Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy. Clin Exp Allergy 2007 37 : 564 71.
9. Petersen AB, Gudmann P, Milvang-Gronager P et al. Performance evaluation of a specific IgE assay developed for the ADVIA centaur immunoassay system. Clin Biochem 2004 37 : 882 92.
10. Boumiza R, Debard AL, Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005 3 : 9.
11. Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy 2004 34 : 332 39.
12. Ebo DG, Sainte-Laudy J, Bridts CH et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy 2006 61 : 1028 39.
13. Marsh DG, Norman PS, Roebber M, Lichtenstein LM. Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J Allergy Clin Immunol 1981 68 : 449 59.
14. Oude Elberink HNG, Kleinjans HA, de Groot H. Comparison of a modified yellow jacket venom extract (allergoid) with conventional yellow jacket venom (aluminum hydroxide bounded) for the treatment of yellow jacket allergy by sting challenges. J Allergy Clin Immunol 2007 119 : S32.
15. Ibarrola I, Sanz ML, Gamboa PM et al. Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts. Clin Exp Allergy 2004 34 : 303 9.
16. Cirkovic T, Gavrovic-Jankulovic M, Prisic S et al. The influence of a residual group in low-molecular-weight allergoids of Artemisia vulgaris pollen on their allergenicity, IgE- and IgG-binding properties. Allergy 2002 57 : 1013 20.
17. Kalinski P, Lebre MC, Kramer D, De Jong EC, Van Schijndel JW, Kapsenberg ML. Analysis of the CD4+ T cell responses to house dust mite allergoid. Allergy 2003 58 : 648 56.
18. Dormann D, Ebner C, Jarman ER, Montermann E, Kraft D, Reske-Kunz AB. Responses of human birch pollen allergen-reactive T cells to chemically modified allergens (allergoids). Clin Exp Allergy 1998 28 : 1374 83.
19. Klimek L, Dormann D, Jarman ER, Cromwell O, Riechelmann H, Reske-Kunz AB. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis. Clin Exp Allergy 1999 29 : 1326 35.
20. van Ree R, van Leeuwen WA, Aalberse RC. How far can we simplify in vitro diagnostic for grass pollen allergy? A study with 17 whole pollen extracts and purified natural and recombinant major allergens. J Allergy Clin Immunol 1998 102 : 184 90.
21. Spiegelberg HL, Beck L, Stevenson DD, Ishioka GY. Recognition of T cell epitopes and lymphokine secretion by rye grass allergen Lolium perenne I-specific human T cell clones. J Immunol 1994 152 : 4706 11.
22. Schenk S, Breiteneder H, Susani M, Najafian N, Laffer S, Duchene M et al. T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): evidence for crossreacting and non-crossreacting T-cell epitopes within grass group I allergens. J Allergy Clin Immunol 1995 96 : 986 96.
23. Muller WD, Karamfilov T, Fahlbusch B, Vogelsang H, Jager L. Analysis of human T cell clones reactive with group V grass pollen allergens. Int Arch Allergy Immunol 1994 105 : 391 6.
24. Wurtzen PA, Bufe A, Wissenbach M et al. Identification of isoform-specific T-cell epitopes in the major timothy grass pollen allergen, Phl p 5. Clin Exp Allergy 1999 29 : 1614 25.
25. Wurtzen PA, Lund L, Lund G, Holm J, Millner A, Henmar H. Chemical modification of birch allergen extract leads to a reduction in allergenicity as well as immunogenicity. Int Arch Allergy Immunol 2007 144 : 287 95.
26. Gupta RK, Rost BE, Relyveld E, Siber GR. Adjuvant properties of aluminum and calcium compunds. In : Powell MF, Newman NJ, eds. Pharmaceutical biotechnology: vaccine design: the subunit and adjuvant approach. New York : Plenum Press, 1995 : 229 48.
27. Lüderitz-Püchel U, Haustein D. Neubewertung des Risikos von Test- und Therapieallergenen - Eine Analyse der UWA-Meldungen von 1991 bis 2000. Bundesgesunsheitbl-Gesundheitforsch-Gesundheitsschutz 2001 44 : 709 18.
28. Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005 60 : 801 7.